DekaBank Deutsche Girozentrale
MDCO

DekaBank Deutsche Girozentrale’s Medicines Co MDCO Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-23,600
Closed -$1.98M – 1199
2019
Q4 		$1.98M Sell
23,600
-41,900
-64% -$2.79M 0.01% 518
2019
Q3 		$3.2M Sell
65,500
-40,700
-38% -$1.62M 0.02% 434
2019
Q2 		$3.81M Buy
106,200
+68,400
+181% +$2.23M 0.02% 477
2019
Q1 		$1.53M Buy
37,800
+1,100
+3% +$25.9K 0.01% 667
2018
Q4 		$696K Sell
36,700
-1,100
-3% -$25.6K ﹤0.01% 768
2018
Q3 		$1.53M Sell
37,800
-300
-0.8% -$11.3K 0.01% 679
2018
Q2 		$1.36M Sell
38,100
-1,800
-5% -$58.5K 0.01% 680
2018
Q1 		$1.33M Buy
39,900
+8,400
+27% +$262K 0.01% 651
2017
Q4 		$1.15M Hold
31,500
– – 0.01% 658
2017
Q3 		$1.15M Hold
31,500
– – 0.01% 666
2017
Q2 		$1.21M Hold
31,500
– – 0.01% 640
2017
Q1 		$1.54M Buy
31,500
+23,500
+294% +$1.07M 0.01% 535
2016
Q4 		$275K Sell
8,000
-64,600
-89% -$2.29M ﹤0.01% 774
2016
Q3 		$2.77M Hold
72,600
– – 0.03% 404
2016
Q2 		$2.45M Buy
72,600
+39,900
+122% +$1.41M 0.03% 432
2016
Q1 		$1.01M Sell
32,700
-1,300
-4% -$42.5K 0.01% 544
2015
Q4 		$1.27M Buy
34,000
+700
+2% +$26.5K 0.01% 538
2015
Q3 		$1.26M Buy
33,300
+1,500
+5% +$52.7K 0.02% 520
2015
Q2 		$910K Buy
31,800
+1,100
+4% +$30.6K 0.01% 586
2015
Q1 		$860K Sell
30,700
-4,200
-12% -$118K 0.01% 597
2014
Q4 		$965K Sell
34,900
-3,200
-8% -$79.3K 0.01% 568
2014
Q3 		$850K Buy
38,100
+800
+2% +$20.3K 0.01% 542
2014
Q2 		$1.08M Sell
37,300
-1,100
-3% -$29.4K 0.02% 487
2014
Q1 		$1.09M Buy
38,400
+2,900
+8% +$96K 0.02% 465
2013
Q4 		$1.37M Buy
35,500
+700
+2% +$25K 0.02% 371
2013
Q3 		$1.17M Buy
+34,800
New +$1.11M 0.02% 406

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

DekaBank Deutsche Girozentrale's MDCO Position: Q1 2020 in Review

DekaBank Deutsche Girozentrale sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 23,600 shares — an estimated $1.98M sold.

DekaBank Deutsche Girozentrale first reported a position in MDCO in Q3 2013 and held it in 26 quarters. The position peaked at $3.81M in Q2 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • DekaBank Deutsche Girozentrale reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 23,600 Medicines Co shares in Q1 2020, an estimated $1.98M.
  • DekaBank Deutsche Girozentrale first reported a position in Medicines Co in Q3 2013 and held it in 26 quarters.
  • DekaBank Deutsche Girozentrale's Medicines Co position peaked at $3.81M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2020, filed 14 May 2020.